Non-Small Cell Lung Cancer: Epidemiology, Risk Factors, Treatment, and Survivorship
Top Cited Papers
- 1 May 2008
- journal article
- Published by Elsevier in Mayo Clinic Proceedings
- Vol. 83 (5), 584-594
- https://doi.org/10.1016/s0025-6196(11)60735-0
Abstract
No abstract availableThis publication has 98 references indexed in Scilit:
- Genome-wide association scan of tag SNPs identifies a susceptibility locus for lung cancer at 15q25.1Nature Genetics, 2008
- Thoracoscopic Lobectomy Is a Safe and Versatile ProcedureAnnals of Surgery, 2006
- Somatic mutations of epidermal growth factor receptor signaling pathway in lung cancersInternational Journal of Cancer, 2006
- Gefitinib plus best supportive care in previously treated patients with refractory advanced non-small-cell lung cancer: results from a randomised, placebo-controlled, multicentre study (Iressa Survival Evaluation in Lung Cancer)The Lancet, 2005
- Epidermal Growth Factor Receptor Mutations in Non–Small-Cell Lung Cancer: Implications for Treatment and Tumor BiologyJournal of Clinical Oncology, 2005
- EGF receptor gene mutations are common in lung cancers from “never smokers” and are associated with sensitivity of tumors to gefitinib and erlotinibProceedings of the National Academy of Sciences, 2004
- Determinants of Tumor Response and Survival With Erlotinib in Patients With Non—Small-Cell Lung CancerJournal of Clinical Oncology, 2004
- EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib TherapyScience, 2004
- Activating Mutations in the Epidermal Growth Factor Receptor Underlying Responsiveness of Non–Small-Cell Lung Cancer to GefitinibNew England Journal of Medicine, 2004
- Early Lung Cancer Action Project: overall design and findings from baseline screeningThe Lancet, 1999